Baricitinib (Olumiant▼): increased risk of diverticulitis, particularly in patients with risk factors

2020-08-26T14:08:31+01:00

Use baricitinib with caution in patients with diverticular disease and in those concomitantly treated with medications associated with an increased risk of diverticulitis.